Abstract
Nephrotic syndrome is a glomerular disorder characterized by heavy proteinuria and hypoalbuminemia. Autoantibodies against slit diaphragm proteins such as nephrin and podocin have been identified in subsets of patients, but their prevalence and clinical significance in adult-onset disease are not fully understood. We retrospectively studied 114 adults with biopsy-proven nephrotic syndrome, including minimal change nephrotic syndrome, focal segmental glomerulosclerosis, and phospholipase A2 receptor- and neural epidermal growth factor-like 1-associated membranous nephropathy. Serum anti-nephrin and anti-podocin autoantibodies were quantified using enzyme-linked immunosorbent assays.
Anti-nephrin autoantibodies were detected predominantly in minimal change nephrotic syndrome (38.2%) and less frequently in focal segmental glomerulosclerosis (14.3%), but were rare in membranous nephropathy. In contrast, anti-podocin autoantibodies were observed across disease types and were most frequent in neural epidermal growth factor-like 1-associated membranous nephropathy (30.8%). Autoantibody-positive patients presented with more severe nephrotic syndrome, and antibody positivity was associated with a higher incidence of steroid-dependent nephrotic syndrome in exploratory multivariable analyses. In patients with paired samples, autoantibody titers decreased or disappeared in remission.
Notably, anti-nephrin antibodies were preferentially associated with MCNS, whereas anti-podocin antibodies were detected across disease entities and may reflect the extent of podocyte injury rather than disease specificity. Moreover, combined assessment of anti-nephrin and anti-podocin antibody status provided improved stratification of baseline disease severity and relapse-prone disease compared with anti-nephrin antibody status alone.
Similar content being viewed by others
Data availability
The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Kidney Disease: Improving Global Outcomes Glomerular Diseases Work G. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 100(4S), S1–S276. https://doi.org/10.1016/j.kint.2021.05.021 (2021).
Rosenberg, A. Z. & Kopp, J. B. Focal segmental glomerulosclerosis. Clin. J. Am. Soc. Nephrol. 12(3), 502–517. https://doi.org/10.2215/CJN.05960616 (2017).
Santin, S. et al. Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome. Clin. J. Am. Soc. Nephrol. 6(5), 1139–1148. https://doi.org/10.2215/CJN.05260610 (2011).
Hildebrandt, F. Genetic kidney diseases. Lancet 375(9722), 1287–1295. https://doi.org/10.1016/S0140-6736(10)60236-X (2010).
Shalhoub, R. J. Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 2(7880), 556–560. https://doi.org/10.1016/s0140-6736(74)91880-7 (1974).
Sellier-Leclerc, A. L. et al. A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cells. J. Am. Soc. Nephrol. 18(10), 2732–2739. https://doi.org/10.1681/ASN.2006121346 (2007).
Cravedi, P., Kopp, J. B. & Remuzzi, G. Recent progress in the pathophysiology and treatment of FSGS recurrence. Am. J. Transplant. 13(2), 266–274. https://doi.org/10.1111/ajt.12045 (2013).
Maas, R. J., Deegens, J. K., Smeets, B., Moeller, M. J. & Wetzels, J. F. Minimal Change Disease and idiopathic FSGS: Manifestations of the same disease. Nat. Rev. Nephrol. 12(12), 768–776. https://doi.org/10.1038/nrneph.2016.147 (2016).
Watts, A. J. B. et al. Discovery of autoantibodies targeting Nephrin in Minimal Change Disease supports a novel autoimmune etiology. J. Am. Soc. Nephrol. 33(1), 238–252. https://doi.org/10.1681/ASN.2021060794 (2022).
Raglianti, V. et al. Anti-slit diaphragm antibodies on kidney biopsy identify pediatric patients with steroid-resistant nephrotic syndrome responsive to second-line immunosuppressants. Kidney Int. 106(6), 1124–1134. https://doi.org/10.1016/j.kint.2024.09.006 (2024).
Raglianti, V. et al. Anti-slit antibodies against Podocin and Kirrel1 in pediatric and adult podocytopathies. J. Am. Soc. Nephrol. 36(4), 702–705. https://doi.org/10.1681/ASN.0000000642 (2025).
Hayashi, N. et al. Glomerular mannose-binding lectin deposition in intrinsic antigen-related membranous nephropathy. Nephrol. Dial. Transplant. 33(5), 832–840. https://doi.org/10.1093/ndt/gfx235 (2018).
Nishi, S. et al. Evidence-based clinical practice guidelines for nephrotic syndrome 2014. Clin. Exp. Nephrol. 20(3), 342–370. https://doi.org/10.1007/s10157-015-1216-x (2016).
Hengel, F. E., Huber, T. B. & Tomas, N. M. Potential and pitfalls of measuring circulating anti-nephrin autoantibodies in glomerular diseases. Clin. Kidney J. 18(5), sfaf100. https://doi.org/10.1093/ckj/sfaf100 (2025).
Shu, Y. et al. Anti-nephrin antibodies in adult Chinese patients with minimal change disease and primary focal segmental glomerulosclerosis. Kidney Int. https://doi.org/10.1016/j.kint.2025.02.028 (2025).
Shirai, Y. et al. A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrence. Kidney Int. 105(3), 608–617. https://doi.org/10.1016/j.kint.2023.11.022 (2024).
Martin, C. E. & Jones, N. Nephrin signaling in the podocyte: An updated view of signal regulation at the slit diaphragm and beyond. Front Endocrinol (Lausanne) 9, 302. https://doi.org/10.3389/fendo.2018.00302 (2018).
Perico, L., Conti, S., Benigni, A. & Remuzzi, G. Podocyte-actin dynamics in health and disease. Nat. Rev. Nephrol. 12(11), 692–710. https://doi.org/10.1038/nrneph.2016.127 (2016).
Hogan, S. L., Muller, K. E., Jennette, J. C. & Falk, R. J. A review of therapeutic studies of idiopathic membranous glomerulopathy. Am. J. Kidney Dis. 25(6), 862–875. https://doi.org/10.1016/0272-6386(95)90568-5 (1995).
Vivarelli, M., Massella, L., Ruggiero, B. & Emma, F. Minimal change disease. Clin. J. Am. Soc. Nephrol. 12(2), 332–345. https://doi.org/10.2215/CJN.05000516 (2017).
Harvey, B. J. & de la Alvarez Rosa, D. Sex differences in kidney health and disease. Nephron 149(2), 77–103. https://doi.org/10.1159/000541352 (2025).
Doublier, S. et al. Testosterone and 17β-estradiol have opposite effects on podocyte apoptosis that precedes glomerulosclerosis in female estrogen receptor knockout mice. Kidney Int. 79(4), 404–413. https://doi.org/10.1038/ki.2010.398 (2011).
Funding
This work was supported by Ministry of Education, Culture, Sports, Science, and Technology Grants-in-Aid for Scientific Research (KAKENHI 24K19138) (to Y.K.).
Author information
Authors and Affiliations
Contributions
N. Hayashi and R. Akai designed the study; N. Hayashi, R. Akai, and T. Iwawaki carried out the experiments; N. Hayashi, Y. Kagaya and K. Fujimoto collected human blood samples. N. Hayashi, H. Yokoyama and K. Furuichi drafted and revised the manuscript. All authors have read and approved the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hayashi, N., Akai, R., Kagaya, Y. et al. Autoantibodies against nephrin and podocin are associated with disease severity and steroid dependence in adult-onset nephrotic syndrome. Sci Rep (2026). https://doi.org/10.1038/s41598-026-43612-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-43612-7
